Charles Ng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Charles Ng has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Craig B. Thompson
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, USA
34 shared publications - Carlos Carmona-Fontaine
Center for Genomics and Systems Biology, Department of Biology, New York University, New York City, NY, United States of America
33 shared publications - Francesco V. Cimino
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York
33 shared publications - Kaloyan M. Tsanov
Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, USA
33 shared publications - Manon Ros
Center for Genomics and Systems Biology, Department of Biology, New York University, New York, USA
33 shared publications - Scott W. Lowe
Memorial Sloan Kettering Cancer Center, New York, NY
33 shared publications
Latest Publications
- Open Access
Mitochondrial ATP production promotes T cell differentiation and function by regulating chromatin accessibility
Summary: Immune elimination of chronic infection or cancer requires cytotoxic CD8 + T cells that adopt and maintain an effector phenotype. Cytotoxic T cell function is a bioenergetically demanding process and T cells subjected to chronic antigen exposure have compromised effector function despite high rates of glycolysis. Here we report the ability of the short-chain α-hydroxy acid, D-α-hydroxybutyrate, to act as a signaling molecule that increases mitochondrial ATP production and drives the conversion of proliferating T cells into cytotoxic effector cells. DAHB signaling switches ATP production from glycolysis to oxidative phosphorylation supported by fatty acid oxidation, even in glucose-replete media. This conversion suppresses both AMPK phosphorylation and the integrated stress response (ISR) in activated T cells while significantly elevating the level of the phosphagen, phosphocreatine (PCr). Both the PCr bioenergetic reserve and oxidative phosphorylation were required for T cell effector differentiation. DAHB-induction of CD8-effector gene transcription was coupled to bioenergetics by enhanced ATP-dependent remodeling of chromatin accessibility at effector gene loci. DAHB enhanced CD8 + T cell antitumor activity both in vitro and in vivo, and DAHB treatment of transferred T cells led to persistent in vivo antitumor effects. Together, these findings link cellular bioenergetics to the regulation of chromatin accessibility and gene expression required to support effector function.
Open AccessMitochondrial ATP production promotes T cell differentiation and function by regulating chromatin accessibility
Summary: Immune elimination of chronic infection or cancer requires cytotoxic CD8 + T cells that adopt and maintain an effector phenotype. Cytotoxic T cell function is a bioenergetically demanding process and T cells subjected to chronic antigen exposure have compromised effector function despite high rates of glycolysis. Here we report the ability of the short-chain α-hydroxy acid, D-α-hydroxybutyrate, to act as a signaling molecule that increases mitochondrial ATP production and drives the conversion of proliferating T cells into cytotoxic effector cells. DAHB signaling switches ATP production from glycolysis to oxidative phosphorylation supported by fatty acid oxidation, even in glucose-replete media. This conversion suppresses both AMPK phosphorylation and the integrated stress response (ISR) in activated T cells while significantly elevating the level of the phosphagen, phosphocreatine (PCr). Both the PCr bioenergetic reserve and oxidative phosphorylation were required for T cell effector differentiation. DAHB-induction of CD8-effector gene transcription was coupled to bioenergetics by enhanced ATP-dependent remodeling of chromatin accessibility at effector gene loci. DAHB enhanced CD8 + T cell antitumor activity both in vitro and in vivo, and DAHB treatment of transferred T cells led to persistent in vivo antitumor effects. Together, these findings link cellular bioenergetics to the regulation of chromatin accessibility and gene expression required to support effector function.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 4, related to Figures 4 and 6
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 4, related to Figures 4 and 6
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 1, related to Figure 1
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 1, related to Figure 1
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 2, related to Figure 2
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 2, related to Figure 2
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 3, related to Figure 3
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 3, related to Figure 3
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 3, related to Figure 3
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 3, related to Figure 3
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 1, related to Figure 1
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 1, related to Figure 1
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 4, related to Figures 4 and 6
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 4, related to Figures 4 and 6
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 2, related to Figure 2
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 2, related to Figure 2
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 1, related to Figure 1
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 1, related to Figure 1